These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28602711)

  • 1. Patients' perceptions and attitudes on recurrent prostate cancer and hormone therapy: Qualitative comparison between decision-aid and control groups.
    Gorawara-Bhat R; O'Muircheartaigh S; Mohile S; Dale W
    J Geriatr Oncol; 2017 Sep; 8(5):368-373. PubMed ID: 28602711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early salvage hormonal therapy for biochemical failure improved survival in prostate cancer patients after neoadjuvant hormonal therapy plus radiation therapy--a secondary analysis of irish clinical oncology research group 97-01.
    Mydin AR; Dunne MT; Finn MA; Armstrong JG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):101-8. PubMed ID: 22658512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels: Results from a Qualitative Analysis.
    Shen MJ; Nelson CJ; Peters E; Slovin SF; Hall SJ; Hall M; Herrera PC; Leventhal EA; Leventhal H; Diefenbach MA
    Med Decis Making; 2015 May; 35(4):477-86. PubMed ID: 25385751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
    van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
    Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a web-based prostate cancer treatment decision aid on patient-reported decision process parameters: results from the Prostate Cancer Patient Centered Care trial.
    Cuypers M; Lamers RED; Kil PJM; van de Poll-Franse LV; de Vries M
    Support Care Cancer; 2018 Nov; 26(11):3739-3748. PubMed ID: 29752528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a decision aid on newly diagnosed prostate cancer patients' understanding of the rationale for active surveillance.
    Formica MK; Wason S; Seigne JD; Stewart TM
    Patient Educ Couns; 2017 May; 100(5):812-817. PubMed ID: 27923674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decision aid versus shared decision making for prostate cancer screening: results of a randomized, controlled trial.
    Stamm AW; Banerji JS; Wolff EM; Slee A; Akapame S; Dahl K; Massman I I I JD; Soung MC; Pittenger KR; Corman JM
    Can J Urol; 2017 Aug; 24(4):8910-8917. PubMed ID: 28832310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.
    Moul JW; Wu H; Sun L; McLeod DG; Amling C; Donahue T; Kusuda L; Sexton W; O'Reilly K; Hernandez J; Chung A; Soderdahl D
    J Urol; 2004 Mar; 171(3):1141-7. PubMed ID: 14767288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The language of prostate cancer treatments and implications for informed decision making by patients.
    Rot I; Ogah I; Wassersug RJ
    Eur J Cancer Care (Engl); 2012 Nov; 21(6):766-75. PubMed ID: 22574619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "The booklet helped me not to panic": a pilot of a decision aid for asymptomatic women with ovarian cancer and with rising CA-125 levels.
    Anderson C; Carter J; Nattress K; Beale P; Philp S; Harrison J; Juraskova I
    Int J Gynecol Cancer; 2011 May; 21(4):737-43. PubMed ID: 21412158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial.
    Cuypers M; Lamers RE; Kil PJ; van de Poll-Franse LV; de Vries M
    Trials; 2015 May; 16():231. PubMed ID: 26012700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of a patient decision aid on decisional conflict related to PSA testing: a structural equation model.
    Stephens RL; Xu Y; Volk RJ; Scholl LE; Kamin SL; Holden EW; Stroud LA
    Health Psychol; 2008 Nov; 27(6):711-721. PubMed ID: 19025266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rising PSA in nonmetastatic prostate cancer.
    Moul JW; Bañez LL; Freedland SJ
    Oncology (Williston Park); 2007 Nov; 21(12):1436-45; discussion 1449, 1452, 1454. PubMed ID: 18077992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodology of patient care for elevated PSA after prostate cancer treatment: A primary care perspective.
    Baum N; Levy J
    Postgrad Med; 2015 Aug; 127(6):654-9. PubMed ID: 26118565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local recurrence of prostate cancer: hormone therapy].
    Altwein JE; Ebert T
    Urologe A; 2006 Oct; 45(10):1276, 1278-82. PubMed ID: 16998661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informed decision making before prostate-specific antigen screening: Initial results using the American Cancer Society (ACS) Decision Aid (DA) among medically underserved men.
    Gökce MI; Wang X; Frost J; Roberson P; Volk RJ; Brooks D; Canfield SE; Pettaway CA
    Cancer; 2017 Feb; 123(4):583-591. PubMed ID: 27727462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy.
    Valentini AL; Gui B; D'Agostino GR; Mattiucci G; Clementi V; Di Molfetta IV; Bonomo P; Mantini G
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):719-24. PubMed ID: 22436789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
    Pacyna JE; Kim S; Yost K; Sedlacek H; Petereit D; Kaur J; Rapkin B; Grubb R; Paskett E; Chang GJ; Sloan J; Basch E; Major B; Novotny P; Taylor J; Buckner J; Parsons JK; Morris M; Tilburt JC
    BMC Cancer; 2018 Aug; 18(1):788. PubMed ID: 30081846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.